Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
In the latest session, Impact BioMedical Inc (AMEX: IBO) closed at $0.55 up 10.45% from its previous closing price of $0.50. In other words, the price has increased by $10.45 from its previous closing price. On the day, 1.31 million shares were traded.
Ratios:
For a deeper understanding of Impact BioMedical Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.25 and its Current Ratio is at 0.25. In the meantime, Its Debt-to-Equity ratio is 2.08 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 04 ’25 when DSS, INC. sold 890,800 shares for $0.95 per share. The transaction valued at 845,013 led to the insider holds 161,100 shares of the business.
Chan Heng Fai Ambrose sold 351,555 shares of IBO for $174,020 on Apr 03 ’25. The Director now owns 0 shares after completing the transaction at $0.49 per share. On Apr 02 ’25, another insider, Chan Heng Fai Ambrose, who serves as the Director of the company, sold 884,776 shares for $0.60 each. As a result, the insider received 533,636 and left with 351,555 shares of the company.
Stock Price History:
Over the past 52 weeks, IBO has reached a high of $6.17, while it has fallen to a 52-week low of $0.37. The 50-Day Moving Average of the stock is -43.87%, while the 200-Day Moving Average is calculated to be -67.73%.
Shares Statistics:
A total of 11.50M shares are outstanding, with a floating share count of 10.07M. Insiders hold about 12.50% of the company’s shares, while institutions hold 2.03% stake in the company.
